Spatial transcriptomics is the computational and experimental framework that quantifies gene expression while retaining the precise two-dimensional coordinates of each transcript within a histological sample. Unlike single-cell RNA sequencing (scRNA-seq), which dissociates tissue and loses positional information, spatial methods overlay transcriptomic data directly onto tissue morphology, enabling the study of cellular communication within native microenvironments.
Glossary
Spatial Transcriptomics

What is Spatial Transcriptomics?
Spatial transcriptomics is a family of molecular profiling technologies that maps the entire transcriptome onto the physical architecture of a tissue section, preserving the locational context of gene expression.
The computational analysis of spatial data relies on specialized algorithms for tissue domain segmentation, spatially variable gene detection, and ligand-receptor interaction mapping across physical distances. By integrating transcriptomic profiles with histological imaging, these methods reveal how cellular neighborhoods and architectural gradients drive biological function in contexts such as tumor immunology and neurodevelopment.
Key Features of Spatial Transcriptomics
Spatial transcriptomics bridges the gap between high-throughput sequencing and tissue histology, mapping gene expression to its native physical coordinates. These core features define the technology's analytical power.
Tissue Architecture Preservation
Unlike dissociation-based single-cell RNA-seq, spatial methods retain the extracellular matrix and cellular neighborhoods. This allows direct correlation of gene expression patterns with histological features like tumor margins, necrotic cores, or lymphoid follicles. The spatial context reveals ligand-receptor interactions that occur only within specific tissue microenvironments.
Unbiased Whole-Transcriptome Capture
Technologies like 10x Visium use spatially barcoded oligonucleotide arrays to capture polyadenylated mRNA across entire tissue sections. This hypothesis-free approach maps the complete transcriptome without prior gene selection. The resulting data enables discovery of novel spatial gene expression signatures and unexpected cell-state transitions that targeted panels might miss.
Computational Deconvolution
Each spatial capture spot often contains multiple cells. Deconvolution algorithms (e.g., RCTD, SPOTlight, cell2location) integrate scRNA-seq reference data to estimate cell-type proportions per spot. This transforms mixed pixel signals into interpretable cell-type maps, enabling analysis of immune infiltration gradients and tumor-immune interfaces without single-cell resolution hardware.
Spatially Variable Gene Detection
Statistical frameworks like SpatialDE and SPARK-X identify genes whose expression depends on spatial location, not just cell identity. These spatially variable genes often encode morphogens, guidance cues, or extracellular matrix remodeling factors. Detecting them reveals the molecular gradients that orchestrate tissue patterning during development and disease progression.
Multi-Modal Spatial Integration
Advanced platforms now co-register transcriptomics with protein detection (e.g., CITE-seq spatial, GeoMx DSP) or histological imaging (H&E, immunofluorescence). This multi-modal fusion anchors molecular data to morphological landmarks. Deep learning models like GNNs and vision transformers jointly embed image patches and gene expression vectors, learning features invisible to either modality alone.
Ligand-Receptor Interaction Mapping
Tools like CellChat, NicheNet, and stLearn infer cell-cell communication by analyzing co-expression of ligand and receptor gene pairs within spatial neighborhoods. Unlike dissociated single-cell methods, spatial context constrains which interactions are physically possible. This identifies signaling hubs and juxtacrine interactions that drive tissue homeostasis or tumor immunosuppression.
Spatial Transcriptomics vs. Single-Cell RNA-seq
Comparison of spatial context preservation versus cellular resolution in transcriptomic profiling technologies
| Feature | Spatial Transcriptomics | scRNA-seq | Combined Approach |
|---|---|---|---|
Spatial context preserved | |||
Single-cell resolution | |||
Tissue architecture intact | |||
Requires tissue dissociation | |||
Captures cell-cell interactions | |||
Dropout rate | Moderate | High | Reduced |
Typical gene detection per spot/cell | 1,000-3,000 | 2,000-5,000 | 3,000-6,000 |
Throughput (cells/spots) | 1,000-10,000 spots | 500-20,000 cells | Integrated |
Applications of Spatial Transcriptomics
Spatial transcriptomics bridges the gap between high-throughput single-cell sequencing and classical histology, enabling researchers to map gene expression directly onto tissue architecture. This spatial context is critical for understanding tumor microenvironments, neural circuits, and developmental gradients.
Tumor Microenvironment Deconvolution
Mapping the cellular niche surrounding malignant cells to identify immunosuppressive barriers. Spatial data reveals how cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs) organize to shield tumors from immune infiltration.
- Identifies ligand-receptor interactions at the invasive margin
- Reveals metabolic coupling between hypoxic cores and proliferative edges
- Guides combination immunotherapy targeting specific spatial neighborhoods
Neuroscience Circuit Mapping
Assigning transcriptomic identities to neurons while preserving their laminar positions and projection patterns. Spatial technologies resolve the layered architecture of brain regions like the cortex and hippocampus.
- Correlates ion channel expression with electrophysiological properties across layers
- Maps disease-associated genes to vulnerable neuronal subpopulations
- Validates in situ hybridization data with unbiased whole-transcriptome coverage
Developmental Biology Trajectories
Capturing gene expression gradients across developing embryos to understand axis formation and organogenesis. Spatial context preserves the morphogen gradients lost in dissociated single-cell methods.
- Reconstructs anterior-posterior patterning in limb buds
- Identifies signaling centers like the floor plate and notochord
- Links transient progenitor states to their physical coordinates
Drug Target Localization
Validating therapeutic targets by confirming their expression in disease-relevant tissue compartments. Spatial analysis prevents pursuing targets expressed only in healthy bystander cells.
- Confirms target engagement in the correct histological structure
- Assesses on-target/off-tissue toxicity risks in clearance organs
- Prioritizes targets enriched at pathological interfaces like the fibrotic niche
Companion Diagnostics Development
Building spatial biomarkers that predict treatment response based on cellular organization patterns rather than bulk expression alone. The spatial arrangement of immune infiltrates often predicts checkpoint inhibitor response better than total abundance.
- Quantifies tertiary lymphoid structure (TLS) maturity and proximity
- Measures the distance between CD8+ T cells and PD-L1+ tumor cells
- Defines exclusion vs. infiltration phenotypes as binary classifiers
Infectious Disease Pathology
Characterizing host-pathogen interactions within their native tissue context. Spatial transcriptomics reveals how viruses like SARS-CoV-2 or Mycobacterium tuberculosis remodel the local cellular ecosystem.
- Identifies the cell types susceptible to viral entry receptor expression
- Maps the spatial organization of granulomas in tuberculosis
- Reveals bystander damage signatures in uninfected neighboring cells
Frequently Asked Questions
Clear, technical answers to the most common questions about mapping gene expression within intact tissue architecture.
Spatial transcriptomics is a family of molecular profiling technologies that quantify gene expression while preserving the physical location of each transcript within a tissue section. Unlike single-cell RNA sequencing (scRNA-seq), which dissociates tissue and loses spatial context, spatial methods overlay transcriptomic data onto histological images. The core mechanism varies by platform: imaging-based methods (e.g., MERFISH, seqFISH+) use fluorescent probes and sequential hybridization to localize transcripts directly in cells, while sequencing-based methods (e.g., 10x Visium, Slide-seq) capture RNA onto spatially barcoded arrays before next-generation sequencing. The output is a gene expression matrix with spatial coordinates, enabling researchers to map cell types, identify tissue niches, and analyze ligand-receptor interactions within their native microenvironment. This preserves the architectural relationships critical for understanding tumor heterogeneity, neural circuit function, and developmental gradients.
Enabling Efficiency, Speed & Accuracy
Intelligent Analysis, Decision & Execution
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Talk to Us
Search across company data
Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.
Useful when people spend too long searching or get different answers from different systems.

Automate internal workflows
Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.
Useful when repetitive work moves across multiple tools and teams.

Add AI to products and internal tools
Build assistants, guided actions, or decision support into the software your team or customers already use.
Useful when AI needs to be part of the product, not a separate tool.
Related Terms
Core computational and experimental concepts that intersect with spatial transcriptomics workflows, from tissue preparation to data integration.
scRNA-seq
Single-cell RNA sequencing profiles the transcriptome of individual cells, resolving heterogeneity masked in bulk sequencing. While scRNA-seq dissociates tissue and loses spatial context, it provides the cell-type resolution that spatial transcriptomics maps back onto tissue architecture. Integration of scRNA-seq reference data enables cell-type deconvolution of spatial spots.
Data Integration
Computational alignment of multiple datasets to remove batch effects while preserving true biological variation. In spatial transcriptomics, integration methods like Harmony, scVI, and Seurat's CCA align spatial data with scRNA-seq references, enabling robust cell-type annotation and cross-condition comparisons across tissue sections.
Ligand-Receptor Analysis
Computational inference of cell-cell communication by mapping ligand expression in one cell type to cognate receptor expression in neighboring cells. Spatial transcriptomics adds physical proximity constraints to these predictions, distinguishing paracrine signaling from endocrine effects. Tools like CellChat and NicheNet incorporate spatial coordinates to validate predicted interactions.
Cell Type Annotation
Assignment of biological identity labels to cell clusters or spatial spots using curated marker gene databases and reference mapping. In spatial contexts, annotation must account for mixed cell types within capture spots. Algorithms like RCTD and cell2location perform spatially-aware deconvolution to estimate cell-type proportions at each coordinate.
Multimodal Integration
Fusion of disparate data types into unified representations. Spatial transcriptomics increasingly combines with immunofluorescence, H&E histology, and spatial proteomics. Methods like SpatialGlue and MultiVI jointly model gene expression, protein abundance, and tissue morphology to resolve tissue architecture with multi-omic depth.
Dimensionality Reduction
Mathematical transformation of high-dimensional spatial data into lower-dimensional space using PCA, t-SNE, or UMAP. Spatial transcriptomics adds the challenge of preserving spatial autocorrelation—the tendency for nearby cells to share transcriptional states. Methods like SpatialPCA explicitly model spatial covariance during embedding.

About the author
Prasad Kumkar
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
Partnered with leading AI, data, and software stack.
How We Work
Custom AI workflows for your Business
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
01
Review the use case
We understand the task, the users, and where AI can actually help.
Read more02
Pick the right approach
We define what needs search, automation, or product integration.
Read more03
Build the first useful version
We implement the part that proves the value first.
Read more04
Improve from there
We add the checks and visibility needed to keep it useful.
Read moreThe first call is a practical review of your use case and the right next step.
Talk to Us